GlassScriptPhysician profile
Rohann Lloyd Whittingham
NPI 1245736123
$906.50
in general payments reported to CMS, 2019-2025
12 companies · $211 in 2025
The $211 reported for 2025 was more than what 77% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.45 · 2022: $174 · 2023: $214 · 2024: $279 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $312.22 | 2022-2025 | Dalvance |
| Astrazeneca Pharmaceuticals LP | $111.21 | 2023-2024 | Lokelma |
| E.R. Squibb & Sons, L.L.C. | $93.14 | 2022-2023 | Eliquis, Camzyos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.70 | 2023-2024 | Xifaxan |
| Aimmune Therapeutics, INC. | $71.00 | 2023-2024 | |
| Pfizer INC. | $64.81 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $47.18 | 2022-2023 | Ultomiris |
| Merck Sharp & Dohme LLC | $36.94 | 2024-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $28.41 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $24.99 | 2023 | Inpefa |
| Boston Scientific Corporation | $21.95 | 2025 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $15.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohann Whittingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.